Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1GGZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,420
Award facts
- Contract value 100% obligated
- $12,420.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 20, 2026, the Defense Logistics Agency awarded a delivery order valued at $12,420.22 to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) for the supply of KESIMPTA 20 MG/0.4 ML pen auto-injectors. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with a completion date of January 21, 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. KESIMPTA is a prescription immunosuppressant medication used in the treatment of multiple sclerosis and other autoimmune conditions, indicating this delivery supports the Defense Health System's pharmaceutical supply chain requirements.
This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of prescription medications, specialty drugs, vaccines, and medical supplies to military treatment facilities and federal healthcare systems worldwide. As a critical pharmaceutical prime vendor for the Department of Defense, AmerisourceBergen maintains a strong competitive position in the federal medical procurement market and regularly fulfills specialized medication requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F1GGZ?
SPE2DR26F1GGZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F1GGZ worth?
The government has obligated $12,420 on SPE2DR26F1GGZ.
Is contract SPE2DR26F1GGZ an order under another contract?
Yes. SPE2DR26F1GGZ is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1GGZ competed?
The extent of competition for SPE2DR26F1GGZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award